Biocon Received Approval in India for its Liraglutide Drug Substance

Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...

Andhra Pradesh Issues Covid-19 Warning, Urges Precautions

Amid the renewed surge in Covid-19 cases across the country, Andhra Pradesh Information and Public Relations Minister K Parthasarathi on Sunday called on citizens to stay alert and follow precautionary guidelines...

Healthy Kids, Pregnant Women No Longer Need COVID Shots: U.S.

U.S. Health Secretary Robert F. Kennedy Jr. declared that COVID-19 vaccines would no longer be routinely recommended for pregnant women and healthy children, bypassing the CDC’s standard advisory process...

Dr Reddy's API Unit in Telangana Gets 2 USFDA Observations

After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...

FDA Advisers Urge COVID Shots to Target JN.1 Variant Strains

A panel of advisers to the U.S. Food and Drug Administration (FDA) unanimously recommended that COVID-19 vaccines for the 2025–26 season target updated strains of the JN.1 variant, and particularly...

IATA Awards CEIV Pharma Certificate to FedEx Global Healthcare

FedEx Corp. (NYSE: FDX) has gained recognition from the International Air Transport Association (IATA) through its CEIV Pharma Corporate Certification which values its strong commitment to handling pharmaceuticals well across the world...

India's Implant Market to Reach USD 5 Billion by FY28 on Strong Demand

India’s Implant Market to Reach USD 5 Billion by FY28 on Strong DemandIndia's orthopaedic and cardiac implant industry is likely to grow to USD 4.5–5 billion by FY2027-28, almost twice the size it is today at USD 2.4–2.7 billion in FY24...

Generic Drugmakers May Avoid Major Impact from Trump Price Cuts

US President Donald Trump’s new price range for Rx drugs with other developed countries might not affect the generic companies in India.

JB Pharma sets Asia Book of Record for Highest MICRAL conducted for Hypertension Patients in India

JB Pharma is making significant strides in the fight against hypertension and its impact on kidney health, in India. On the occasion of the upcoming ‘World Hypertension Day’ celebrated on 17th May

Glaxosmithkline Pharmaceuticals Posts 34.7% Surge in Q4 Net Profit

The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025.

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring